Intermolecular Stockholders Agree to Merck KGaA Acquisition
18 Julho 2019 - 5:40AM
Dow Jones News
By Anthony Shevlin
Merck KGaA (MRK.XE) said Thursday that Intermolecular Inc. (IMI)
stockholders have approved the acquisition by the German
company.
The transaction is expected to close in the second half, Merck
said.
The pharmaceutical company agreed to acquire Intermolecular in
May through a subsidiary for $1.20 per share in an all-cash
transaction, which represented an equity value of around $62
million.
Merck will acquire Intermolecular through its subsidiary EMD
Group Holding II, Inc.
Write to Anthony Shevlin at anthony.shevlin@dowjones.com;
@anthony_shevlin
(END) Dow Jones Newswires
July 18, 2019 04:25 ET (08:25 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Intermolecular (NASDAQ:IMI)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Intermolecular (NASDAQ:IMI)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Intermolecular Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Intermolecular, Inc.